Clinical Trial Update: AngelMed for Early Recognition and Treatment of STEMI [Phase 3]

View source ↗

Summary

Phase 3 trial update for the AngelMed Guardian System targeting STEMI, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• AngelMed Guardian System

Snippet

Sponsor: Angel Medical Systems | Conditions: Acute Myocardial Infarction (AMI), Coronary Occlusion | Phase 3 | Status: COMPLETED